Kyntra Bio (KYNB) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced with introductions of board members, general counsel, and auditor, and outlined the agenda for the session.

• Stockholders as of April 16, 2026, were eligible to vote, and procedural matters for voting and Q&A were explained.

• Notice of the meeting was sent to all stockholders of record starting April 27, 2026.

Board and executive committee updates

• Dr. Michael Kauffman was nominated for election as Class III director to serve until the 2029 annual meeting.

Shareholder proposals

• Three proposals were presented: election of a director, advisory approval of executive compensation, and ratification of the independent auditor.